Orion Portfolio Solutions LLC decreased its holdings in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 22.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,300 shares of the medical equipment provider’s stock after selling 3,514 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Integer were worth $1,599,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Contravisory Investment Management Inc. raised its stake in shares of Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 80 shares during the period. Huntington National Bank grew its holdings in Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 268 shares in the last quarter. Quest Partners LLC increased its position in shares of Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Integer by 74.1% in the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after buying an additional 278 shares in the last quarter. Finally, Innealta Capital LLC bought a new position in shares of Integer in the second quarter valued at approximately $110,000. Institutional investors own 99.29% of the company’s stock.
Analysts Set New Price Targets
A number of analysts recently weighed in on ITGR shares. Citigroup upped their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday. Piper Sandler reiterated an “overweight” rating and issued a $140.00 price objective (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Wells Fargo & Company restated an “overweight” rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Bank of America upped their target price on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. Finally, KeyCorp lifted their price target on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $145.44.
Integer Price Performance
ITGR opened at $138.65 on Friday. The stock has a market capitalization of $4.65 billion, a P/E ratio of 42.73, a PEG ratio of 2.02 and a beta of 1.12. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. Integer Holdings Co. has a 12-month low of $94.56 and a 12-month high of $142.76. The stock has a 50-day moving average price of $133.58 and a 200-day moving average price of $125.61.
Integer (NYSE:ITGR – Get Free Report) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. The business had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.27 earnings per share. Equities analysts predict that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.
About Integer
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also
- Five stocks we like better than Integer
- What is the Shanghai Stock Exchange Composite Index?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Expert Stock Trading Psychology Tips
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Upcoming IPO Stock Lockup Period, Explained
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.